Literature DB >> 20386090

Hyperinsulinemic hypoglycemia associated with ectopic Cushing's syndrome due to a pancreatic endocrine tumor in a Type 2 diabetes mellitus patient: clinical implications of a rare association.

M Filippella1, M V Davì, G Doveri, E Lillaz, A Ciccarelli, E Massimetti, M Toaiari, M Falconi, A Colao, A Faggiano.   

Abstract

BACKGROUND: The coexistence of insulin and ACTH hypersecretion in the same patient is extremely rare. A diabetic patient with a pancreatic endocrine tumor (PET) co-secreting insulin and ACTH is even rarer and has never been described. The combination of these two endocrine syndromes results in a peculiar clinical picture. AIM: To determine the cause of glycemic variations in a patient with previously stable diabetes mellitus. SUBJECTS AND METHODS: This is a clinical case report from the Endocrinology Unit of Aosta Hospital and Internal Medicine and Surgical Unit of Verona University. A 69-yr-old diabetic patient was hospitalized for recurrent severe hypoglycemic events persistent after withdrawal of anti-diabetic drugs. The causes of hypoglycemia and subsequent resumption of hyperglycemia were investigated.
RESULTS: An insulin-secreting PET was diagnosed. Diazoxide and octreotide therapy initially was able to control hypoglycemic symptoms, then, a Cushing's syndrome occurred resulting in worsening of diabetes control. ACTH was found to be released by the PET previously diagnosed as an insulin-secreting tumor. The tumor was removed and the histology was consistent with a well differentiated endocrine carcinoma. After surgery, adrenal function was normal and insulin therapy was again necessary to control diabetes.
CONCLUSIONS: A single PET may be responsible for both a hyperinsulinemic and a Cushing's syndrome. When this rare association occurs, each of the two syndromes may affect the other resulting in a peculiar clinical course. Finally, an insulin-secreting PET has to be kept in mind as a rare cause of hypoglycemia in diabetic patients.

Entities:  

Mesh:

Year:  2010        PMID: 20386090     DOI: 10.1007/BF03347062

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  31 in total

Review 1.  Cushing's syndrome.

Authors:  M Boscaro; L Barzon; F Fallo; N Sonino
Journal:  Lancet       Date:  2001-03-10       Impact factor: 79.321

2.  Pancreas: Insulinoma--new insights into an old disease.

Authors:  Maria Vittoria Davì; Massimo Falconi
Journal:  Nat Rev Endocrinol       Date:  2009-06       Impact factor: 43.330

3.  Pancreatic insuloma causing Cushing's syndrome.

Authors:  F Torriani; A Uske; E Temler; F Rey; J Hurlimann; B Delaloye; F Gomez
Journal:  J Endocrinol Invest       Date:  1989-05       Impact factor: 4.256

Review 4.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

5.  [Ectopic Cushing's syndrome caused by a functioning pancreatic neuroendocrine tumour in a patient with von Hippel-Lindau disease].

Authors:  A Benítez Velazco; C Pacheco Capote; J M Latre Romero
Journal:  Rev Esp Med Nucl       Date:  2008 Jan-Feb

6.  Insulinoma in a patient with NIDDM.

Authors:  L A Kane; C S Grant; T B Nippoldt; F J Service
Journal:  Diabetes Care       Date:  1993-09       Impact factor: 19.112

7.  Primary hepatic carcinoid tumor presenting as Cushing's syndrome.

Authors:  N A Shah; I A Urusova; A D'Agnolo; S D Colquhoun; B E Rosenbloom; S L Vener; S A Geller; M Younes; J Lechago; A P Heaney
Journal:  J Endocrinol Invest       Date:  2007-04       Impact factor: 4.256

8.  Insulinoma accompanied by diabetes mellitus.

Authors:  Takashi Nagai; Makoto Imamura; Yoshiki Takai; Masatomo Mori
Journal:  Diabetes Res Clin Pract       Date:  2003-04       Impact factor: 5.602

9.  Insulinoma and gastrinoma syndromes from a single intrapancreatic neuroendocrine tumor.

Authors:  Maya B Lodish; Anathea C Powell; Mones Abu-Asab; Craig Cochran; Petra Lenz; Steven K Libutti; James F Pingpank; Maria Tsokos; Phillip Gorden
Journal:  J Clin Endocrinol Metab       Date:  2008-02-05       Impact factor: 5.958

10.  Pancreatic neuroendocrine tumor with ectopic adrenocorticotropin production upon second recurrence.

Authors:  Konstanze Miehle; Andrea Tannapfel; Peter Lamesch; Gudrun Borte; Eva Schenker; Regine Kluge; Rudolf A Ott; Volker Wiechmann; Martin Koch; Woubet Kassahun; Ralf Paschke; Christian A Koch
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

View more
  3 in total

1.  Presentation, diagnostic features and glucose handling in a monocentric series of insulinomas.

Authors:  M Toaiari; M V Davì; L Dalle Carbonare; L Boninsegna; C Castellani; M Falconi; G Francia
Journal:  J Endocrinol Invest       Date:  2013-04-18       Impact factor: 4.256

2.  A case of insulin and ACTH co-secretion by a neuroendocrine tumour.

Authors:  S Solomou; R Khan; D Propper; D Berney; M Druce
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2014-02-01

3.  Metastatic insulinoma presenting after bariatric surgery in a patient diagnosed with MEN1.

Authors:  Caroline Poku; Hafsa Amjed; Fatima Kazi; Shanika Samarasinghe
Journal:  Clin Case Rep       Date:  2022-02-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.